Menu
Home
GPcardio CVD, CKD & T2D About EPCCS About IPCCS NCD Academy EACH WONCA World 2025
EPCCS
About EPCCS Connected Societies GPcardio About IPCCS
Education
Lipid Management in ... Cardio Renal Update Cardiovascular Updat... The EU Cardiovascula... Cardiovascular Disea... Managing CV risk in ...
Resources
Practice Guidance Meeting reports STRATIFYHF Recent News Video updates WONCA World 2025
Literature
Left Atrial Appendag... 26 Mar. Novel cardiovascular... 26 Mar. Systemic Inflammatio... 24 Mar. Use of Coronary Arte... 16 Mar. 2026 ACC/AHA Guideli... 13 Mar. Off-label underdosin... 12 Mar. Semaglutide promotes... 9 Mar. Effect of baxdrostat... 7 Mar. More Literature

Feb. 9, 2021

2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease

A Report of the American College of Cardiology Solution Set Oversight Committee.

Dharam J Kumbhani, Christopher P Cannon, Craig J Beavers et al. - Journal of the American College of Cardiology

The 2020 ACC Expert Consensus provided a comprehensive decision pathway for managing antithrombotic therapy in patients with atrial fibrillation or venous thromboembolism who require antiplatelet agents, with practical algorithms for diverse clinical scenarios.

Source